Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07424248

Chronic Pain After Combat-Related Traumatic Brain Injury (cTBI-Pain Study) A Prospective Cohort Study of Pain Chronification After Combat-Related Traumatic Brain Injury

Combat-related traumatic brain injury (cTBI), particularly blast-related injury, is frequently associated with the development of persistent and disabling chronic pain. This prospective observational cohort study aims to determine the incidence, phenotypes, and early predictors of chronic pain following mild to moderate combat-related TBI. Adults will be enrolled within 14 days of injury and followed for 6 months. The primary endpoint is clinically significant chronic pain at 3 months, defined by pain intensity and functional interference. The study will evaluate clinical, psychological, and physiological factors to develop and internally validate a prognostic model for chronic pain risk after cTBI.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Combat-related traumatic brain injury (cTBI), particularly blast-associated injury, is a major contributor to the development of chronic pain syndromes in military populations. Pain following cTBI may present as chronic post-traumatic headache, cervicogenic pain, neuropathic pain, or widespread pain associated with central sensitization. The interaction between neuronal injury, psychological stress (including PTSD), sleep disturbance, and associated peripheral trauma creates a high-risk environment for pain chronification.

This prospective observational cohort study will enroll adults with mild to moderate combat-related traumatic brain injury within 14 days of injury. Participants will undergo standardized clinical, psychometric, and physiological assessments during the acute phase and will be followed longitudinally at 6 weeks, 3 months, and 6 months.

Pain intensity will be assessed using the Numerical Rating Scale (NRS) and the Brief Pain Inventory (BPI). Neuropathic pain features will be evaluated using DN4, and central sensitization symptoms using the Central Sensitization Inventory (CSI). Psychological factors including PTSD (PCL-5), depression (PHQ-9), anxiety (GAD-7), and pain catastrophizing (PCS) will be assessed. Sleep disturbance will be evaluated using the Insomnia Severity Index (ISI). Functional outcomes will be measured using WHODAS 2.0 and PROMIS Physical Function. A subgroup of participants will undergo physiological testing, including heart rate variability (HRV) and quantitative sensory testing (QST).

The primary endpoint is clinically significant chronic pain at 3 months, defined as NRS ≥4 and/or BPI interference score ≥4. Secondary outcomes include neuropathic pain phenotype, functional impairment, psychological outcomes, and persistent analgesic use at 6 months.

Multivariable regression modeling, including logistic regression and penalized methods (LASSO), will be used to identify independent predictors of chronic pain. Internal validation will be performed using bootstrapping techniques. Model performance will be evaluated using ROC-AUC and calibration metrics.

The study aims to develop a clinically applicable risk prediction model to identify individuals at high risk for chronic pain following combat-related TBI and to inform early preventive and rehabilitative interventions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 to 60 years
  • Combat-related traumatic brain injury (blast, impact, or combined mechanism)
  • Mild to moderate traumatic brain injury
  • Enrollment within 14 days after injury
  • Ability to provide written informed consent

Exclusion criteria

  • Severe traumatic brain injury with prolonged impaired consciousness
  • Pre-existing severe psychiatric disorder unrelated to trauma
  • Chronic pain condition predating the traumatic brain injury
  • Inability to complete follow-up assessments
  • Severe medical condition limiting participation

Treatment and study plan

Primary outcomes

  1. Clinically significant chronic pain at 3 months after injury.

    Time frame: From injury to 3 months (±2 weeks) post-injury.

    Clinically significant chronic pain is defined as pain intensity ≥4 on the 0-10 Numerical Rating Scale (NRS) and/or pain interference score ≥4 on the Brief Pain Inventory (BPI) at 3 months post-injury. The proportion of participants meeting this definition will be calculated, and predictors of chronic pain will be evaluated using multivariable modeling.

Secondary outcomes

  1. Clinically significant chronic pain at 6 months

    Time frame: 6 months (±3 weeks) after injury

    Presence of chronic pain defined as NRS ≥4 and/or BPI interference score ≥4 at 6 months post-injury.

  2. Neuropathic pain phenotype

    Time frame: 3 and 6 months after injury

    Presence of neuropathic pain features defined as DN4 score ≥4.

Study contacts

Contact information is provided by the study sponsor or research team.

Dmytro Dmytriiev, PhD.Professor

CONTACT

[email protected]

+380674309449

Sponsors and collaborators

Lead sponsor

Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans)

Other

Registry information

Acronym: TBI-Pain

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Feb 20, 2026
Registry last updated
Feb 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.